Research Story Tip: Grants, Management Roles Keep Johns Hopkins A Leader In Hiv/Aids Clinical Trial

Date: 12/08/2020

Publication:

hopkinsmedicine.org

This World AIDS Day, HIV/AIDS researchers at Johns Hopkins Medicine learned that they now have an enhanced opportunity to help move the world toward a day when that observance is rendered obsolete. The National Institutes of Health (NIH)’s National Institute of Allergy and Infectious Diseases (NIAID) announced Dec. 1, 2020, that Johns Hopkins Medicine will receive five of the seven-year grants awarded to 35 U.S. and international institutions to operate clinical trial units (CTUs) and coordinate HIV/AIDS clinical trials in four federally funded networks.

The three CTU grants and two leadership awards for Johns Hopkins Medicine are the most given to any one institution.

Full Article Here

Clinical Trials

P1077FF: Formula Feeding Version of the PROMISE Study...

1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...

Read More

Identification of Biomarkers That Can Predict Progression...

Purpose: The C-TRIUMPH study has identified 20 household contacts (HHC), who have progressed to active TB from its HHCs cohort...

Read More

P2010: Phase III Study of the Virologic Efficacy and Safety...

IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...

Read More

A5322: Long-Term Follow-up of Older HIV-infected Adults in...

The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...

Read More

A5274: REMEMBER, Reducing Early Mortality and Early...

This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...

Read More